Michael R. Lucey

Michael R. Lucey

Gastroenterology | Hepatology | Transplant Surgery

750 University Row
Madison, WI 53705

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 152 publications

Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice.

Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice.

Journal: Gut microbes

Published: July 09, 2026

Treatment of Acute Liver Failure (ALF) and Acute on Chronic Liver Failure (ACLF): from Pig to Man.

Treatment of Acute Liver Failure (ALF) and Acute on Chronic Liver Failure (ACLF): from Pig to Man.

Journal: Gastroenterology

Published: June 10, 2026

Early Liver Transplantation: The Last Chance Therapy for Patients With Alcohol-Associated Hepatitis and Acute on Chronic Liver Failure.

Early Liver Transplantation: The Last Chance Therapy for Patients With Alcohol-Associated Hepatitis and Acute on Chronic Liver Failure.

Journal: British journal of hospital medicine (London, England : 2005)

Published: April 20, 2026

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis.

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis.

Journal: Clinical and translational gastroenterology

Published: March 13, 2026

AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation.

AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation.

Journal: Hepatology (Baltimore, Md.)

Published: November 18, 2025

AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation.

AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation.

Journal: Hepatology (Baltimore, Md.)

Published: November 18, 2025

Prioritising phosphatidylethanol to aid classification and treatment of steatotic liver disease.

Prioritising phosphatidylethanol to aid classification and treatment of steatotic liver disease.

Journal: The lancet. Gastroenterology & hepatology

Published: August 18, 2025

Measles Outbreaks 2025 and Beyond: Implications for Immunosuppressed Patients Managed by Gastroenterologists and Hepatologists.

Measles Outbreaks 2025 and Beyond: Implications for Immunosuppressed Patients Managed by Gastroenterologists and Hepatologists.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 21, 2025

Reducing alcohol-associated liver disease burden in the general population.

Reducing alcohol-associated liver disease burden in the general population.

Journal: The lancet. Gastroenterology & hepatology

Published: March 10, 2025

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice.

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: February 11, 2025

Alcohol-associated liver disease is associated with less adverse outcomes compared to nonalcohol-associated liver disease in patients with COVID-19.

Alcohol-associated liver disease is associated with less adverse outcomes compared to nonalcohol-associated liver disease in patients with COVID-19.

Journal: Alcohol, clinical & experimental research

Published: February 11, 2025

Reply to: "Do not leave any ambiguity: Alcohol in any amount is harmful".

Reply to: "Do not leave any ambiguity: Alcohol in any amount is harmful".

Journal: Journal of hepatology

Published: February 07, 2025

Showing 1-12 of 152

Last Updated: 09/26/2026